Prediction of late adverse events in pelvic cancer patients receiving definitive radiotherapy using radiation-induced gamma-H2AX foci assay.
J Radiat Res
; 64(6): 948-953, 2023 Nov 21.
Article
in En
| MEDLINE
| ID: mdl-37839163
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pelvic Neoplasms
/
Histones
Limits:
Female
/
Humans
Language:
En
Journal:
J Radiat Res
Year:
2023
Document type:
Article